CapsoVision will release Q2 2026 financial results on August 13
The company will host a conference call and webcast at 1:30 pm PT on August 13 to discuss the results and provide a corporate update.
See the latest news and media coverage for CapsoVision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company specializing in gastrointestinal diagnostic imaging
capsovision.comLast updated
In short: CapsoVision advanced its AI-enabled capsule endoscopy portfolio, secured $14 million in funding, and appointed a new board member.
The company will host a conference call and webcast at 1:30 pm PT on August 13 to discuss the results and provide a corporate update.
A conference call and webcast will follow at 1:30 pm PT that day.
Revenue grew 13% in Q4 and 15% for the year, with new accounts up 16% and 21% respectively.
The proceeds will be used for general corporate purposes, including sales, marketing, and R&D.
CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the Company will release ...
On July 1, 2026, CapsoVision appointed veteran gastroenterologist and longtime clinical advisor Dr. David S. Shields to its Board of Directors and Compensation Committee, filling...
Joanne Imperial, a director at CapsoVision, Inc. (CV), reported a sale of company common stock on June 8, 2026. The transaction involved the disposition of...
CapsoVision (NASDAQ:CV) reported steady first-quarter revenue and said it continues to advance artificial intelligence and capsule endoscopy programs aimed at expanding the use of its...
Track CapsoVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.